| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Dishman Pharmaceuticals and Chemicals Limited (NSE: DISHMAN)
DISHMAN Technical Analysis
1
| As on N/A DISHMAN SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
DISHMANSHARE Price
| Open | N/A | Change | Price | % |
| High | N/A | 1 Day | N/A | N/A |
| Low | N/A | 1 Week | N/A | N/A |
| Close | N/A | 1 Month | N/A | N/A |
| Volume | N/A | 1 Year | N/A | N/A |
| 52 Week High N/A | 52 Week Low N/A | ||||
NSE INDIA Most Active Stocks
| IDEA | 12.95 | -1.52% |
| YESBANK | 23.95 | 0.00% |
| ONGC | 283.15 | 1.18% |
| EXIDEIND | 459.80 | 12.41% |
| NHPC | 91.20 | 2.53% |
| IDFCFIRSTB | 82.70 | -0.06% |
| PNB | 128.55 | -3.24% |
| ZOMATO | 186.45 | -0.98% |
| DHANI | 48.00 | 15.38% |
| TATASTEEL | 160.05 | -0.50% |
NSE INDIA Top Gainers Stocks
| DSSL | 1131.95 | 20.00% |
| HINDMOTORS | 21.95 | 19.95% |
| WABAG | 923.90 | 15.50% |
| DHANI | 48.00 | 15.38% |
| BHAGERIA | 185.45 | 15.15% |
| AKASH | 40.95 | 13.43% |
| MARKSANS | 176.70 | 13.38% |
| EXIDEIND | 459.80 | 12.41% |
| JAGSNPHARM | 321.45 | 11.89% |
| SOTL | 542.55 | 10.85% |
NSE INDIA Top Losers Stocks
| DISHMAN Daily Charts |
DISHMAN Intraday Charts |
Whats New @ Bazaartrend |
DISHMAN Free Analysis |
|
|
DISHMAN Important Levels Intraday
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE |
DISHMAN Target April 2024
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
DISHMAN Weekly Target
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
DISHMAN Target2024
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
Dishman Pharmaceuticals and Chemicals Limited ( NSE INDIA Symbol : DISHMAN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DISHMAN Synopsis Technicals View
| 50 Day EMA |
Close is Below EMA 50 (Short Term) |
Bearish | |
| 100 Day EMA | Close is Below EMA 100 (Mid Term) | Bearish | |
| 200 Day EMA | N/A (Long Term) | N/A | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 51.92 | Sideways | |
| MFI (14) | MFI is 47.25 | Sideways | |
| CCI (20) | CCI is -35.68 | Sideways | |
| WILLIAM %R (14) | William %R is -30.62 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Above -DI | Up Trend | |
| PSAR | Stoploss For Short Sell | 262.00 | |
| 10 Day Avg Volume | Traded 52.93 % More then 10 Day Average Volume | ||
DISHMAN Other Details
| Segment | EQ | |
| Market Capital | 2137643520.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > | |
DISHMAN Address
 |
Bhadr-Raj Chambers Swastik Cross Road Ahmedabad, 380009 India Phone: 91 79 2644 3053 Fax: 91 79 2642 0198 |
|
DISHMAN Latest News
DISHMAN Business Profile
Dishman Pharma is in the Pharmaceuticals sector. The Dishman Group was founded in 1983 by Shri Janmejay R. Vyas, Managing Director of the Dishman Group. Since the beginning, the focus of the Dishman Group has been on research and development of various in-house technologies for the manufacture of quaternary ammonium compounds (quats) and active pharmaceutical ingredients. The first facility of the Dishman Group was built in 1987 in Naroda; in 1996 the company initiated its expansion at Bavla where it is currently headquartered. Through several acquisitions, the Dishman Group became a global company with multiple manufacturing facilities in India, Europe and China serving pharmaceutical and biopharmaceutical companies.
Dishman employs over 1,000 people worldwide and delivered annual net sales of around US$200m 2011. Dishman is headquartered in Ahmedabad, India and is listed on the Bombay Stock Exchange (BSE).
The current market capitalisation stands at Rs 654.45 crore.The company has reported a consolidated sales of Rs 354.95 crore and a Net Profit of Rs 42.28 crore for the quarter ended Sep 2013.
The company management includes Janmejay R Vyas - Chairman & Managing Director, Deohooti J Vyas - Whole Time Director, Arpit J Vyas - Whole Time Director, Yagneshkumar B Desai - Director, Sanjay S Majmudar - Director, Ashok C Gandhi - Director.
It is listed on the BSE with a BSE Code of 532526 and the NSE with an NSE Code of DISHMAN.
Its Registered office is at Bhadr - Raj Chambers, Swastik Cross Road,,Navrangpura. Ahmedabad,Gujarat - 380009.
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service